Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-11-06
1989-09-12
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548215, A61K 3142, C07D49810
Patent
active
048660833
ABSTRACT:
An oxazolidine derivative of phenylephrine, and the non-toxic pharmaceutically acceptable salt forms thereof. The prodrug is much quicker absorbed across the cornea of the eye, does not induce the same unwanted side effects as phenylephrine, and can produce the same mydriatic effect as phenylephrine at dosage levels of approximately one-tenth the level of phenylephrine.
REFERENCES:
patent: 2243295 (1941-05-01), Susie et al.
patent: 4028368 (1977-06-01), Bodor et al.
patent: 4088783 (1978-05-01), Bodor et al.
patent: 4158005 (1979-06-01), Bodor et al.
patent: 4174450 (1979-11-01), Bodor et al.
Chien Du-Shieng
Schoenwald Ronald D.
Shen Cecilia
University of Iowa Research Foundation
LandOfFree
2-t-butyl-3 alkyl-5-(m-hydroxyphenyl)-1,3-oxazolidines having my does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-t-butyl-3 alkyl-5-(m-hydroxyphenyl)-1,3-oxazolidines having my, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-t-butyl-3 alkyl-5-(m-hydroxyphenyl)-1,3-oxazolidines having my will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-916579